CLOZAPINE
| Brand name | FAZACLO ODT |
|---|---|
| Active ingredient | CLOZAPINE |
| Strength | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2010 |
| Marketing status | DISCN |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.